CRP and melanoma: Furthermore, high CRP levels have been reported to induce an immunosuppressive environment by inhibiting T‐cell proliferation and downregulating co‐stimulatory molecules on dendric cells (DCs) in melanoma,20 indicating that CRP blockade is a therapeutic strategy to enhance ICI therapy in cancer.